| 000 | 01271 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513033822.0 | ||
| 264 | 0 | _c19950817 | |
| 008 | 199508s 0 0 eng d | ||
| 022 | _a0959-4973 | ||
| 024 | 7 |
_a10.1097/00001813-199504003-00006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSimmonds, M A | |
| 245 | 0 | 0 |
_aTransdermal fentanyl: clinical development in the United States. _h[electronic resource] |
| 260 |
_bAnti-cancer drugs _cApr 1995 |
||
| 300 |
_a35-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFentanyl _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMorphine _xadministration & dosage |
| 650 | 0 | 4 |
_aPain _xclassification |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aUnited States |
| 773 | 0 |
_tAnti-cancer drugs _gvol. 6 Suppl 3 _gp. 35-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00001813-199504003-00006 _zAvailable from publisher's website |
| 999 |
_c7605472 _d7605472 |
||